Clinical trial
A Phase 3, Open-Label, Safety Study of Lofexidine
NCT02363998 is registered in ClinicalTrials.gov with USWM, LLC (dba US WorldMeds) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Open-Label, Safety Study of Lofexidine
- Lead sponsor
- USWM, LLC (dba US WorldMeds)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- October 31, 2015
- Enrollment
- 286 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
opioid withdrawal